|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
|
EP0773952B1
(en)
*
|
1994-07-20 |
2003-11-12 |
The General Hospital Corporation |
Interaction trap systems for detecting protein interactions
|
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
|
DE69535829D1
(de)
|
1994-08-20 |
2008-10-16 |
Gendaq Ltd |
Verbesserung in bezug auf bindungsproteine bei der erkennung von dna
|
|
US20050002902A1
(en)
*
|
1995-12-28 |
2005-01-06 |
Liming Yu |
Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
|
|
US6365344B1
(en)
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
|
DE69722176T2
(de)
*
|
1996-01-23 |
2004-03-18 |
The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto |
Verfahren zur suche nach transdominanten effektorpeptiden und rna-molekülen
|
|
US5955275A
(en)
|
1997-02-14 |
1999-09-21 |
Arcaris, Inc. |
Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
|
|
US6060240A
(en)
*
|
1996-12-13 |
2000-05-09 |
Arcaris, Inc. |
Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
|
|
US6623922B1
(en)
|
1997-02-14 |
2003-09-23 |
Deltagen Proteomics |
Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
US6969584B2
(en)
|
1997-06-12 |
2005-11-29 |
Rigel Pharmaceuticals, Inc. |
Combinatorial enzymatic complexes
|
|
DE19737562A1
(de)
*
|
1997-08-28 |
1999-05-06 |
Otogene Biotechnologische Fors |
Verfahren zur Identifizierung von Wechselwirkungen zwischen Proteinen bzw. Peptiden
|
|
AU1582799A
(en)
*
|
1997-11-07 |
1999-05-31 |
Iconix Pharmaceuticals, Inc. |
Surrogate genetics target characterization method
|
|
US6197502B1
(en)
*
|
1997-11-17 |
2001-03-06 |
Cytos Biotechnology Ag |
Expression cloning processes for the discovery characterization, and isolation of genes encoding polypeptides with a predetermined property
|
|
US6846625B1
(en)
|
1998-01-09 |
2005-01-25 |
Cubist Pharmaceuticals, Inc. |
Method for identifying validated target and assay combination for drug development
|
|
US6475726B1
(en)
|
1998-01-09 |
2002-11-05 |
Cubist Pharmaceuticals, Inc. |
Method for identifying validated target and assay combinations for drug development
|
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
|
DE19805334A1
(de)
*
|
1998-02-11 |
1999-08-12 |
Otogene Biotechnologische Fors |
Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
|
|
EP1053317B1
(en)
|
1998-02-13 |
2006-11-02 |
Köster, Hubert |
Use of ribozymes for functionating genes
|
|
ES2341926T3
(es)
|
1998-03-02 |
2010-06-29 |
Massachusetts Institute Of Technology |
Poliproteinas con dedos de cinc que tienen enlazadores mejorados.
|
|
NZ506987A
(en)
|
1998-03-17 |
2003-01-31 |
Sangamo Biosciences Inc |
Nucleic acid binding proteins
|
|
AU3707099A
(en)
*
|
1998-04-08 |
1999-11-01 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Process for producing cell clone libraries
|
|
CA2327830A1
(en)
*
|
1998-04-09 |
1999-10-21 |
Iconix Pharmaceuticals Inc. |
Methods for identifying genetic determinants associated with modulation of test compound activity
|
|
US8334238B2
(en)
*
|
1998-04-17 |
2012-12-18 |
Rigel, Inc. |
Multiparameter FACS assays to detect alterations in cellular parameters and to screen small molecule libraries
|
|
US6897031B1
(en)
*
|
1998-04-17 |
2005-05-24 |
Rigel Pharmaceuticals, Inc. |
Multiparameter FACS assays to detect alterations in exocytosis
|
|
US6461813B2
(en)
*
|
1998-09-21 |
2002-10-08 |
Rigel Pharmaceuticals, Inc. |
Multiparameter FACS assays to detect alterations in cell cycle regulation
|
|
US7090976B2
(en)
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
|
US20040002056A1
(en)
*
|
1998-05-12 |
2004-01-01 |
Lorens James B. |
Methods of screening for bioactive agents using cells transformed with self-inactivating viral vectors
|
|
US7060433B1
(en)
*
|
1999-11-12 |
2006-06-13 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening using diphtheria toxin constructs
|
|
US7001733B1
(en)
*
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
|
DE19829495A1
(de)
*
|
1998-07-02 |
2000-01-05 |
Jacques Paysan |
Reagenzien und deren Anwendung zur Untersuchung von Wechselwirkungen zwischen zellulären Molekülen und deren Lokalisation in Zellen
|
|
SK692001A3
(en)
*
|
1998-07-20 |
2001-12-03 |
M & E Biotech As |
Novel methods for the identification of ligand and target biomolecules
|
|
EP1270746A1
(en)
*
|
1998-07-20 |
2003-01-02 |
Inoxell A/S |
Methods for the identification of ligand and target biomolecules
|
|
US6472151B1
(en)
|
1998-08-19 |
2002-10-29 |
Bristol-Myers Squibb Company |
Method of screening for compounds that modulate the activity of a molecular target
|
|
WO2000020859A1
(en)
*
|
1998-10-05 |
2000-04-13 |
Duke University |
METHOD AND APPARATUS FOR DETECTING BINDING INTERACTIONS $i(IN VIVO)
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
|
US6453242B1
(en)
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6720139B1
(en)
|
1999-01-27 |
2004-04-13 |
Elitra Pharmaceuticals, Inc. |
Genes identified as required for proliferation in Escherichia coli
|
|
US6342356B1
(en)
|
1999-03-12 |
2002-01-29 |
Gpc Biotech, Inc. |
Methods and regents for identifying synthetic genetic elements
|
|
AU3893000A
(en)
*
|
1999-03-16 |
2000-10-04 |
Dana-Farber Cancer Institute, Inc. |
Lentiviral vector system for high quantity screening
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
DE69918260T2
(de)
*
|
1999-03-29 |
2005-07-14 |
Michael Blind |
Methoden zur Identifizierung und Validierung von funktionellen Zielen mittels Intrameren oder in vivo Selektion
|
|
US6524797B1
(en)
|
1999-05-10 |
2003-02-25 |
Bernhard O. Palsson |
Methods of identifying therapeutic compounds in a genetically defined setting
|
|
EP1183534A2
(en)
*
|
1999-05-25 |
2002-03-06 |
Rigel Pharmaceuticals, Inc. |
Identification of novel mechanisms of drug resistance
|
|
US6737240B1
(en)
|
1999-05-25 |
2004-05-18 |
Rigel Pharmaceuticals, Inc. |
Methods of screening for a multi-drug resistance conferring peptide
|
|
EP1055929A1
(en)
*
|
1999-05-26 |
2000-11-29 |
Tibotec N.V. |
Means and methods for drug discovery and the phenotypic characterisation of cells
|
|
EP1187913A1
(en)
*
|
1999-05-31 |
2002-03-20 |
Novozymes A/S |
Screening method for peptides
|
|
AU2005209649B2
(en)
*
|
1999-05-31 |
2008-05-29 |
Novozymes A/S |
Screening method for peptides
|
|
AU2041901A
(en)
|
1999-11-09 |
2001-06-06 |
Elitra Pharmaceuticals, Inc. |
Genes essential for microbial proliferation and antisense thereto
|
|
AU1482101A
(en)
*
|
1999-11-10 |
2001-06-06 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising renilla gfp
|
|
CA2394850C
(en)
|
1999-12-06 |
2012-02-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
|
EP1242457B1
(en)
*
|
1999-12-28 |
2004-08-11 |
Esbatech AG |
Intrabodies with defined framework that is stable in a reducing environment and applications thereof
|
|
CA2398155C
(en)
|
2000-01-24 |
2011-07-19 |
Sangamo Biosciences, Inc. |
Methods and compositions for linking binding domains in nucleic acid binding proteins
|
|
US6582899B1
(en)
*
|
2000-02-15 |
2003-06-24 |
Deltagen Proteomics, Inc. |
Methods for identifying agents that cause a lethal phenotype, and agents thereof
|
|
US7566765B2
(en)
*
|
2000-03-06 |
2009-07-28 |
Rigel Pharmaceuticals, Inc. |
Heterocyclic compounds containing a nine-membered carbon-nitrogen ring
|
|
US7378248B2
(en)
*
|
2000-03-06 |
2008-05-27 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein-protein interaction
|
|
US7252952B2
(en)
*
|
2000-03-06 |
2007-08-07 |
Rigel Pharmaceuticals, Inc. |
In vivo production of cyclic peptides for inhibiting protein—protein interaction
|
|
US7105341B2
(en)
*
|
2000-03-06 |
2006-09-12 |
Rigel Pharmaceuticals. Inc. |
In vivo production of cyclic peptides
|
|
WO2001075178A2
(en)
*
|
2000-04-04 |
2001-10-11 |
Enanta Pharmaceuticals, Inc. |
Methods for identifying peptide aptamers capable of altering a cell phenotype
|
|
US6762031B2
(en)
*
|
2000-06-16 |
2004-07-13 |
University Of Medicine And Dentistry Of New Jersey |
Targeting viral vectors to specific cells
|
|
US20060258562A1
(en)
*
|
2000-07-31 |
2006-11-16 |
Healor Ltd. |
Methods and pharmaceutical compositions for healing wounds
|
|
WO2002009639A2
(en)
*
|
2000-07-31 |
2002-02-07 |
Bar Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
US20030148924A1
(en)
*
|
2002-07-09 |
2003-08-07 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions of healing wounds
|
|
US20040037828A1
(en)
*
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
|
US20100129332A1
(en)
*
|
2000-07-31 |
2010-05-27 |
Tamar Tennenbaum |
Methods and pharmaceutical compositions for healing wounds
|
|
DE10060959A1
(de)
*
|
2000-12-06 |
2002-06-20 |
Aventis Res & Tech Gmbh & Co |
Verfahren zur Isolierung und Identifizierung von Effektoren
|
|
EP1341914A2
(en)
|
2000-12-07 |
2003-09-10 |
Sangamo Biosciences Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7820447B2
(en)
|
2000-12-22 |
2010-10-26 |
Sagres Discovery Inc. |
Compositions and methods for cancer
|
|
US7700274B2
(en)
|
2000-12-22 |
2010-04-20 |
Sagres Discovery, Inc. |
Compositions and methods in cancer associated with altered expression of KCNJ9
|
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US7645441B2
(en)
|
2000-12-22 |
2010-01-12 |
Sagres Discovery Inc. |
Compositions and methods in cancer associated with altered expression of PRLR
|
|
DK1353941T3
(da)
|
2001-01-22 |
2013-06-17 |
Sangamo Biosciences Inc |
Modificerede zinkfingerbindingsproteiner
|
|
AU2002338446A1
(en)
*
|
2001-01-23 |
2002-11-05 |
University Of Rochester Medical Center |
Methods of producing or identifying intrabodies in eukaryotic cells
|
|
WO2002062822A2
(en)
*
|
2001-02-02 |
2002-08-15 |
University Of Rochester |
Methods of identifying regulator molecules
|
|
JP2004530117A
(ja)
*
|
2001-02-22 |
2004-09-30 |
プラエシス ファーマシューティカルズ インコーポレーテッド |
生物プロセスを調節するペプチドを同定する方法
|
|
IL142481A0
(en)
*
|
2001-04-05 |
2002-03-10 |
Yissum Res Dev Co |
A method for identifying consitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof
|
|
DE10119999A1
(de)
*
|
2001-04-23 |
2002-10-24 |
Univ Heidelberg |
Verfahren zur Identifizierung und Entwicklung von Substanzen oder Substanzgemischen die zelluläre Transport-, Prozessierungs- und Sekretionsprozesse beeinflussen
|
|
US20050255464A1
(en)
*
|
2001-07-19 |
2005-11-17 |
Hagen Frederick S |
Methods for the identification of peptidyl compounds interacting with extracellular target molecules
|
|
GB0118532D0
(en)
*
|
2001-07-30 |
2001-09-19 |
Isis Innovation |
Materials and methods relating to improved vaccination strategies
|
|
WO2003031573A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
|
US7427497B2
(en)
*
|
2001-11-01 |
2008-09-23 |
Rensselaer Polytechnic Institute |
In vitro metabolic engineering on microscale devices
|
|
AU2002361589A1
(en)
*
|
2001-11-06 |
2003-05-19 |
Enanta Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
|
|
US7262054B2
(en)
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
|
US20070105778A1
(en)
|
2002-01-23 |
2007-05-10 |
El-Gewely Mohamed R |
Methods of screening molecular libraries and active molecules identified thereby
|
|
EP1501855A4
(en)
|
2002-03-21 |
2006-02-22 |
Sagres Discovery Inc |
NEW COMPOSITIONS AND METHODS FOR CANCER
|
|
US20030219723A1
(en)
*
|
2002-05-20 |
2003-11-27 |
Lu Henry H. |
Compositions and methods for screening and identifying anti-HCV agents
|
|
AU2003251124A1
(en)
*
|
2002-06-07 |
2003-12-22 |
Sophion Bioscience A/S |
Screening methods
|
|
EP1539951A1
(en)
*
|
2002-06-21 |
2005-06-15 |
Sinogenomax Co., Ltd. |
Randomised dna libraries and double-stranded rna libraries, use and method of production thereof
|
|
US7361635B2
(en)
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
|
CA2500757A1
(en)
*
|
2002-10-09 |
2004-04-22 |
Novozymes A/S |
A method for screening for an antimicrobial polypeptide
|
|
CA2504870A1
(en)
*
|
2002-11-04 |
2004-05-21 |
Bioarctic Neuroscience Ab |
Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
|
|
CA2504922A1
(en)
*
|
2002-11-04 |
2004-05-21 |
Icogenex Corporation |
Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
|
|
EP2058408A3
(en)
|
2003-02-14 |
2009-09-09 |
Sagres Discovery, Inc. |
Therapeutic GPCR targets in cancer
|
|
AU2004231997A1
(en)
*
|
2003-04-16 |
2004-11-04 |
The University Of Mississippi |
Immunostimulatory agents in botanicals
|
|
WO2004094992A2
(en)
*
|
2003-04-23 |
2004-11-04 |
Bioseek, Inc. |
Methods for analysis of biological dataset profiles
|
|
GB0313173D0
(en)
*
|
2003-06-07 |
2003-07-16 |
Givaudan Sa |
Improvements in or related to organic compounds
|
|
RU2491952C2
(ru)
*
|
2003-07-15 |
2013-09-10 |
Бар-Илан Юнивесити |
Способы и фармакологические композиции для заживления ран
|
|
US7776584B2
(en)
*
|
2003-08-01 |
2010-08-17 |
Genetix Limited |
Animal cell colony picking apparatus and method
|
|
WO2005013885A2
(en)
|
2003-08-07 |
2005-02-17 |
Healor Ltd. |
Pharmaceutical compositions and methods for accelerating wound healing
|
|
US20050052687A1
(en)
*
|
2003-08-12 |
2005-03-10 |
Murata Kikai Kabushiki Kaisha |
Image processing device and communication terminal device
|
|
US8530187B2
(en)
*
|
2004-03-22 |
2013-09-10 |
The Ohio State University Research Foundation |
Methods for transfecting natural killer cells
|
|
US7745196B1
(en)
|
2004-03-25 |
2010-06-29 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for identifying peptide modulators of cell surface receptors
|
|
EP1749022A2
(en)
*
|
2004-05-24 |
2007-02-07 |
Rigel Pharmaceuticals, Inc. |
Methods for cyclizing synthetic polymers
|
|
WO2005118629A1
(en)
|
2004-06-02 |
2005-12-15 |
Diatech Pty Ltd |
BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
|
|
WO2006039630A2
(en)
*
|
2004-10-02 |
2006-04-13 |
Indiana University Research & Technology Corporation |
Materials and methods for identifying compounds that modulate the cell cycle
|
|
EP3300739A3
(en)
|
2005-03-31 |
2018-07-18 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161p2f10b proteins
|
|
US20090214536A1
(en)
|
2005-04-07 |
2009-08-27 |
Guoying Yu |
CACNA1E in Cancer Diagnosis, Detection and Treatment
|
|
WO2006110585A2
(en)
|
2005-04-07 |
2006-10-19 |
Novartis Vaccines And Diagnostics Inc. |
Cancer-related genes (prlr)
|
|
EP2452687A3
(en)
*
|
2005-08-29 |
2012-09-05 |
HealOr Ltd. |
Methods and compositions for prevention and treatment of diabetic and aged skin
|
|
WO2007053561A2
(en)
*
|
2005-11-01 |
2007-05-10 |
Rensselaer Polytechnic Institute |
Three-dimensional cellular array chip and platform for toxicology assays
|
|
US8242057B2
(en)
*
|
2006-06-26 |
2012-08-14 |
Cleveland Biolabs, Inc. |
Methods for identifying modulators of apoptosis
|
|
CN101835486B
(zh)
*
|
2007-07-30 |
2012-12-12 |
希尔洛有限公司 |
用于治疗创伤的药物组合物以及相关方法
|
|
CN102325789A
(zh)
*
|
2009-02-24 |
2012-01-18 |
希尔洛有限公司 |
用于治疗痤疮和其它病症的内脂素治疗药物
|
|
CA2760153A1
(en)
*
|
2009-04-27 |
2010-11-11 |
Alex Chenchik |
Reagents and methods for producing bioactive secreted peptides
|
|
US20120064064A1
(en)
*
|
2009-05-28 |
2012-03-15 |
Thil Dinuk Batuwangala |
Antigen-binding proteins
|
|
JP2013516500A
(ja)
|
2010-01-11 |
2013-05-13 |
ヒールオア・リミテッド |
炎症性疾患および障害を治療するための方法
|
|
WO2013016220A1
(en)
|
2011-07-22 |
2013-01-31 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
|
US20130164860A1
(en)
|
2011-11-04 |
2013-06-27 |
Technion Research & Development Foundation Ltd. |
Affinity methods and compositions employing electronic control of ph
|
|
GB2523211B
(en)
|
2012-01-27 |
2020-03-18 |
Univ Jefferson |
MCT protein inhibitor-related prognostic and therapeutic methods
|
|
US20150105274A1
(en)
|
2012-02-10 |
2015-04-16 |
Phylogica Limited |
Methods for the Characterisation of Interaction Sites on Target Proteins
|
|
MX2014013041A
(es)
|
2012-04-27 |
2015-03-19 |
Cytomx Therapeutics Inc |
Anticuerpos activables que se ligan al receptor del factor de crecimiento epidermico y metodos de uso de los mismos.
|
|
GB2505237A
(en)
*
|
2012-08-24 |
2014-02-26 |
Stefan Grimm |
Method of screening for therapeutic agents using cell lines including a reference cell line
|
|
WO2014172627A1
(en)
|
2013-04-19 |
2014-10-23 |
Thomas Jefferson University |
Caveolin-1 related methods for treating glioblastoma with temozolomide
|
|
US9540440B2
(en)
|
2013-10-30 |
2017-01-10 |
Cytomx Therapeutics, Inc. |
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
|
|
US9737623B2
(en)
|
2013-12-11 |
2017-08-22 |
Cytomx Therapeutics, Inc. |
Antibodies that bind activatable antibodies and methods of use thereof
|
|
CA2986388C
(en)
|
2015-06-11 |
2024-02-27 |
Genexine, Inc. |
Modified interleukin-7 protein and uses thereof
|
|
WO2016201409A1
(en)
|
2015-06-12 |
2016-12-15 |
Georgia State University Research Foundation |
Compositions and methods for treating opioid tolerance
|
|
KR102386735B1
(ko)
|
2015-11-06 |
2022-04-14 |
주식회사 제넥신 |
변형된 인터루킨-7 융합 단백질의 제형
|
|
TWI774651B
(zh)
|
2015-12-04 |
2022-08-21 |
南韓商吉耐森股份有限公司 |
包含融合有免疫球蛋白Ｆｃ之介白素-７的用於預防或治療人類乳頭狀瘤病毒相關疾病的藥學組成物
|
|
CN108697764A
(zh)
|
2015-12-04 |
2018-10-23 |
格纳西尼有限公司 |
含有免疫球蛋白fc融合白细胞介素-7融合蛋白的用于预防或治疗流感病毒感染的药物组合物
|
|
EP4281557A4
(en)
*
|
2021-01-19 |
2025-03-19 |
Hope Patents, LLC |
A method for identifying peptide therapeutics to treat a variety of conditions
|